SC
EMN icon

Stance Capital’s Eastman Chemical EMN Stock Holding History

Stance Capital’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16
Closed -$1.01K – 180
2025
Q3 		$1.01K Sell
16
-12,781
-100% -$892K ﹤0.01% 275
2025
Q2 		$955K Buy
+12,797
New +$1.01M 0.36% 136

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stance Capital's EMN Position: Q4 2025 in Review

Stance Capital sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 16 shares — an estimated $1.01K sold.

Stance Capital first reported a position in EMN in Q2 2025 and held it in 2 quarters. The position peaked at $955K in Q2 2025. 633 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Stance Capital reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Stance Capital sold 16 Eastman Chemical shares in Q4 2025, an estimated $1.01K.
  • Stance Capital first reported a position in Eastman Chemical in Q2 2025 and held it in 2 quarters.
  • Stance Capital's Eastman Chemical position peaked at $955K in Q2 2025.
  • 633 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Stance Capital's 13F filing for Q4 2025, filed 17 Mar 2026.